Related Experiment Video
Updated: Dec 23, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.8K
Platelet-inspired therapeutics: current status, limitations, clinical implications, and future potential
Sarah M Kola1, Yahya E Choonara1, Pradeep Kumar1
1Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, Johannesburg, 2193, South Africa.
Drug Delivery and Translational Research
|April 24, 2020
Summary
Platelet-inspired therapeutics offer targeted treatment, overcoming limitations of conventional therapies. This approach enhances drug delivery and biocompatibility for improved patient outcomes in precision medicine.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Regenerative Medicine
Background:
- Conventional therapeutics face challenges in targeted delivery, leading to side effects and delayed action.
- Biocompatibility issues in current treatments reduce patient compliance.
- Precision therapy aims to overcome these limitations through targeted treatment strategies.
Purpose of the Study:
- To review the impact of platelet-inspired systems in therapeutics.
- To explore limitations of current platelet-based therapeutic systems and propose solutions.
- To discuss the clinical implications and future potential of platelet-inspired therapeutics.
Main Methods:
- Review of current literature on platelet-mediated therapeutics and drug delivery.
- Analysis of platelet-inspired systems for targeted therapy.
- Evaluation of biocompatibility and functional retention of platelets in therapeutic applications.
Main Results:
- Platelet-inspired systems demonstrate significant impact in advancing cell-mediated therapeutics.
- These systems offer potential for targeted drug delivery, mitigating systemic side effects.
- Maintaining platelet structure and function addresses biocompatibility concerns.
Conclusions:
- Platelet-inspired therapeutics represent a promising advancement in precision medicine.
- Further research into overcoming system limitations is crucial for clinical translation.
- These novel approaches hold substantial future potential for treating diverse diseases.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
961
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
961
01:22Formation of the Platelet Plug
8.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.4K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
374
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
374
01:18Structure and Function of Platelets
2.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:29Microorganisms in Medicine and Therapeutics
836
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
836